Clinical Profile of Children with Sickle Cell Anaemia in Nasarawa State, Nigeria: A Five – Year Review
Main Article Content
Abstract
BACKGROUND: Sickle cell anaemia (SCA) is a chronic multi-systemic condition characterized by haemoglobin polymerization leading to erythrocytes rigidity, frequent haemolysis and vaso- occlusion. It is an autosomal recessive disorder associated with high morbidity and mortality. The prevalence of the disease varied from one location to the other.
AIM AND OBJECTIVES: This study determined the prevalence in Nasarawa state, the commonest crisis and the risk factors / complications of the disease.
MATERIALS AND METHODS: A hospital-based study of sickle cell anaemic patients seen between January 1st of 2013 to the December 31st of 2018. Hospital records, emergency units register and patients’ folders served as the source of the secondary data. Analysis was done using SPSS version 23. Data was presented in tables, with categorical variables in frequencies and percentages while the continuous variables were presented as mean and stand deviation.
RESULTS: There are slightly more males than females with a ratio of 1.2:0.8. The mean age of diagnosing SCA was 9.7±6.6 years, with 55.7% of cases aged between 5 – 15 years. The prevalence of SCA in Nasarawa state was 0.02%. Two third of reasons for hospital presentation by sickle cell anaemic patients are due to vaso-occlusive crisis. About one in every five presents with deepening jaundice suggestive of hyperhemolytic crisis. Cellulitis and malaria were the commonest triggers leading to hospital admission in this study. Vaso-occlusive crisis warranting admission, while about a third had received blood transfusion at least once.
CONCLUSIONS: The burden of sickle cell anaemia is low in Nasarawa State. Vaso-occlusive crisis is the commonest acute manifestation at admission. Cellulitis and malaria are the leading triggers of such cases warranting hospital admission.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Creary M, Williamson D, Kulkarni R. Sickle cell disease: Current activities, public health implications, and future directions. J Womens Health (Larchmt) 2007;16:575‑82.
Ambe JP, Mava Y, Chama R, Farouq G, Machoko Y. Clinical features of sickle cell anaemia in Northern Nigerian children. West Afr J Med 2012;31:81‑5.
Edwards R, Telfair J, Cecil H, Lenoci J. Reliability and validity of a self‑efficacy instrument specific to sickle cell disease. Behav Res Ther 2000;38:951‑63.
Adam MA, Adam NK, Mohamed BA. Prevalence of sickle cell disease and sickle cell trait among children admitted to Al Fashir Teaching Hospital North Darfur State, Sudan. BMC Res Notes 2019;12:659.
Adewoyin AS. Management of sickle cell disease: A review for physician education in Nigeria (Sub‑Saharan Africa). Anemia 2015;2015:791498.
Schartz J, Puffer ES. Comphrensive Handbook of Childhood Cancer and Sickle Cell Disease: A Biopsycosocial Approach. New York: Oxford University Press; 2006. p. 449‑70.
Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103:4023‑7.
Saganuwan SA. The pattern of sickle cell disease in sickle cell patients in North‑Western Nigeria. Clin Med Insights 2016;8:53‑87.
Raymond TA, Patrick IO, Stephen OO. Prevalence of sickle cell among patients attending immunogenetic diagnostic laboratory Akwanga, Nasarawa state Nigeria. Int J Immunol 2018;6:17‑24.
Emechebe GO, Onyire NB, Oriji ML. Sickle cell diseases in Nigeria (a review). J Dent Med Serv 2017;16:87‑94.
Ejiofor OS, Efobi C, Emechebe GO, Ifezulike CC, Okeke KN, Mokebe TC, et al. Newborn screening for sickle cell disease (SCD) in Awka South East Nigeria. J Blood Disord Transfus 2018;9:398‑400.
Sack FF, Njangtang DM, Chemegni BC and Djientcheu VP. Prevalence of sickle cell disease in newborns in the Yaounde central hospital. J Med Res 2017;3:277‑9.
Olagunju OE, Faremi FA, Olaifa O. Prevalence and burden of sickle cell disease among undergraduates of Obafemi Awolowo University,
Ile – Ife. J Community Med Primary Health Care 2017;29:74‑80.
Stephen N, Nden N, Gusen NJ, Kumzhi PR, Gaknung B, Auta DA,et al. Prevalence of sickle cell disease among children attending plateau specialist hospital, Jos, Nigeria. Acta Med Int 2018;5:20‑3.
Inusa BP, Hsu LL, Kohli N, Patel A, Ominu‑Evbota K, Anie KA,et al. Sickle cell disease‑genetics, pathophysiology, clinical presentation and treatment. Int J Neonatal Screen 2019;5:20.
Kawuki J, Musa TH, Obore N, Papabathini SS. Sickle cell disease in East African countries: Prevalence, complications and managements. J Adv Med Med Res 2019;30:1‑9.
Chakravorty S, Williams TN. Sickle cell disease: A neglected chronic disease of increasing global health importance. Arch Dis Child 2015;100:48‑53.